(Press-News.org) Major randomized controlled trials of new therapies for inflammatory bowel disease (IBD) are conducted on patients who are not typical of those who physicians see in day-to-day practice, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association (AGA).
The two major, often debilitating, illnesses that are recognized as IBD are ulcerative colitis and Crohn's disease. The introduction of biologics — the most prescribed medications for IBD patients — have dramatically impacted the ability to manage disease activity. However, a substantial percentage of IBD patients will have no response to these medications or lose response over time. This fact not only highlights the need for additional investigation of therapeutic targets, but also strategies to identify the optimal scenario for greatest therapeutic effect.
"Many outpatients with moderate-to-severe inflammatory bowel disease may not qualify for trials of new treatment options," said Christina Ha, MD, of the Johns Hopkins School of Medicine and lead author of this study. "Because of the heterogeneity of the inflammatory bowel disease patient population in terms of age of onset, disease behavior and severity, many patients may not meet the strict entry criteria for clinical trial participation. However, we often presume similar therapeutic effect among our clinic patients as demonstrated in clinical trials."
Researchers from the Johns Hopkins School of Medicine, Mount Sinai School of Medicine and Dartmouth-Hitchcock Medical Center performed a retrospective cohort study of 206 adult patients with moderate-to-severe IBD who went to the Mount Sinai Medical Center for an adjustment of their medical therapy from January 2008 to June 2009. Of these patients, only 31.1 percent would have been eligible to participate in a randomized controlled clinical trial of biologics. Reasons for exclusion included structuring or penetrating Crohn's disease, high-dose intake of steroids, comorbidities or prior exposure to biologics, or treatment with topical therapies.
Results from randomized clinical trials form the basis for FDA approval of treatments, expert recommendations and guidelines for the management of IBD patients, and are currently the best approach available to study treatment effects. However, by limiting the available pool of potential study patients through strict inclusion and exclusion criteria in an effort to maximize clinical trial results, these trial results may have limited applicability in the real-world doctor's office.
In addition, limiting selection criteria requires larger study populations, longer durations of follow-up observation and substantially greater cost. However, shifting to a more pragmatic-based approach with minimal study exclusions may help physicians generalize study results to their day-to-day practice as well as support randomized controlled trial findings in a more common clinical practice setting.
###
To learn more about IBD, please read the AGA brochure, "Inflammatory Bowel Disease" at http://www.gastro.org/patient-center/digestive-conditions/inflammatory-bowel-disease.
About the AGA Institute
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org.
About Clinical Gastroenterology and Hepatology
The mission of Clinical Gastroenterology and Hepatology is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology. This monthly peer-reviewed journal includes original articles as well as scholarly reviews, with the goal that all articles published will be immediately relevant to the practice of gastroenterology and hepatology. For more information, visit www.cghjournal.org.
Like AGA, Gastroenterology and Clinical Gastroenterology and Hepatology on Facebook.
Join AGA on LinkedIn.
Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.
Typical IBD patients not represented in research studies
2012-08-22
ELSE PRESS RELEASES FROM THIS DATE:
Deadly outbreak of West Nile virus highlights urgent need for more research, funding
2012-08-22
New Rochelle, NY, August 22, 2012–Mosquito-borne West Nile virus (WNV) caused 26 deaths already this year, and nearly 700 cases had been reported by mid-August according to the Centers for Disease Control and Prevention (CDC). WNV had become "old news" among the public and the media. Furthermore, funding to support research, training and education, and surveillance and vector control had waned. Now there is an urgent imperative to redouble our efforts to understand and control this dangerous virus. Vector-Borne and Zoonotic Diseases, a major peer-reviewed journal from Mary ...
In Fiji, marine protection gets local boost
2012-08-22
NEW YORK (August 20, 2012)—A new study by researchers from the Global Change Institute at the University of Queensland, the ARC Centre of Excellence for Coral Reef Studies at James Cook University, and the Wildlife Conservation Society has found that locally managed marine protected areas within Fiji are playing an increasingly important role in the nation's strategy to protect inshore habitats.
The study estimates that by 2020, locally managed marine protected areas within the Fiji Locally Managed Marine Area (LMMA) network will effectively protect between 12-18 percent ...
Better monitoring of food quantity makes self-control easier
2012-08-22
MINNEAPOLIS / ST. PAUL (08/22/2012) —New research from the University of Minnesota's Carlson School of Management suggests learning how to stop enjoying unhealthy food sooner may play a pivotal role in combating America's obesity problem. The research, published in the Journal of Consumer Research, explores how satiation, defined as the drop in liking during repeated consumption, can be a positive mechanism when it lowers the desire for unhealthy foods.
"When people talk about self-control, they really imply that self-control is willpower and that some people have it ...
Iowa State, Ames Lab researchers study the structure of drug resistance in tuberculosis
2012-08-22
AMES, Iowa – Edward Yu took note of the facts – nearly 2 million deaths each year, 9 million infected each year, developments of multidrug-resistant, extensively drug-resistant and now totally drug-resistant strains – and decided to shift his research focus to tuberculosis.
Yu, an Iowa State University and Ames Laboratory researcher, has described in the journal Nature the three-part structure that allows E. coli bacteria to pump out toxins and resist antibiotics.
And now, in a paper published online by the journal Nucleic Acids Research, a research team led by Yu describes ...
30 minutes of daily exercise does the trick
2012-08-22
Researchers at the University of Copenhagen have shown that 30 minutes of daily training provide an equally effective loss of weight and body mass as 60 minutes. Their results have just been published in the American Journal of Physiology.
Forty percent of Danish men are moderately overweight. For thirteen weeks, a research team at the Faculty of Medical and Health Sciences followed 60 heavy – but healthy – Danish men in their efforts to get into better shape. Half of the men were set to exercise for an hour a day, wearing a heart-rate monitor and calorie counter, while ...
Income, 'screen time' affect soda, junk food consumption
2012-08-22
(Edmonton) Preschoolers from low-income neighbourhoods and kids who spend more than two hours a day in front of a TV or video-game console have at least one thing in common: a thirst for sugary soda and juice, according to research from the University of Alberta.
Researchers from the faculties of Physical Education and Recreation, School of Public Health and Medicine & Dentistry surveyed parents to assess the dietary habits of 1,800 preschoolers in the Edmonton region as part of a larger study on diet, physical activity and obesity.
Researchers found that 54.5 per cent ...
Likely voters say president's 'first 100 days in office' should include plans for research
2012-08-22
WASHINGTON—August 22, 2012— On the eve of the political conventions, nearly two-thirds of likely voters say the next president should announce initiatives promoting medical progress during his "first 100 days in office," according to a new national public opinion poll commissioned by Research!America. And nearly three-quarters of those polled say it's important for candidates for the presidency and Congress to have a science advisor. The findings reveal deep concerns among voters about the lack of attention candidates and elected officials have assigned to research.
"Research ...
Ames Laboratory scientists crack long-standing chemistry mystery
2012-08-22
A team of researchers at the U.S. Department of Energy's (DOE's) Ames Laboratory has answered a key question concerning the widely-used Fenton reaction – important in wastewater treatment to destroy hazardous organic chemicals and decontaminate bacterial pathogens and in industrial chemical production. The naturally occurring reaction was first discovered in 1894 by H.J.H. Fenton, a British chemist at Cambridge, and involves hydrogen peroxide (H2O2) and iron.
How the Fenton reaction actually happens has remained in contention. Scientists have long debated whether it ...
Ancient fossils reveal how the mollusc got its teeth
2012-08-22
TORONTO, ON – The radula sounds like something from a horror movie – a conveyor belt lined with hundreds of rows of interlocking teeth. In fact, radulas are found in the mouths of most molluscs, from the giant squid to the garden snail. Now, a "prototype" radula found in 500-million-year-old fossils studied by University of Toronto graduate student Martin Smith, shows that the earliest radula was not a flesh-rasping terror, but a tool for humbly scooping food from the muddy sea floor.
The Cambrian animals Odontogriphus and Wiwaxia might not have been much to look at ...
UCI microbiologists find new approach to fighting viral illnesses
2012-08-22
Irvine, Calif., Aug. 22, 2012 — By discovering how certain viruses use their host cells to replicate, UC Irvine microbiologists have identified a new approach to the development of universal treatments for viral illnesses such as meningitis, encephalitis, hepatitis and possibly the common cold.
The UCI researchers, working with Dutch colleagues, found that certain RNA viruses hijack a key DNA repair activity of human cells to produce the genetic material necessary for them to multiply.
For many years, scientists have known that viruses rely on functions provided by ...